Thus, it is critical to understand how the complex heterogeneity of the acute CD8+ T cell response is regulated at the molecular level in order to find the best strategies for efficient vaccinations and anti-tumor activities, both of which rely on robust memory. This evidence concerns the gene CD8A and neoplasm.